Safety of High-Dose Daptomycin in Patients With Severe Renal Impairment

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s159587
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Pharmacokinetics and Safety of a Single Dose of Stavudine (D4T) in Patients With Severe Hepatic Impairment.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1997English

The Pharmacokinetics and Safety of Darapladib in Subjects With Severe Renal Impairment

British Journal of Clinical Pharmacology
Pharmacology
2015English

Safety and Efficacy of Ibrutinib in a Patient With Severe Renal Impairment

Hematology Reports
Hematology
2017English

Dose of Gentamicin in Patients With Normal Renal Function and Renal Impairment

BMJ
1968English

Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects With Renal Function Impairment

Antiviral Therapy
Infectious DiseasesPharmacology
2015English

Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects With Severe Renal Impairment

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Pharmacokinetics of Daptomycin in a Patient With Severe Renal Failure Not Receiving Dialysis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2013English

Safety of Bronchial Thermoplasty in High Risk Patients With Severe Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients With Renal Impairment

Pharmacy
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy